Loading…
5 companies · GEL, thousands · columns ordered by revenue
Only 1 of 5 peers filed FY2024. Switch to FY2023 (4 of 5).
| Line item | Diamti | Bakmed | Lateki | Tesio | MN Medikal Georgia |
|---|---|---|---|---|---|
| Total Revenue | 1,794 | — | — | — | — |
| Total COGS | -709 | — | — | — | — |
| Gross Profit | 1,085 | — | — | — | — |
| Gross Margin | 60.5% | — | — | — | — |
| Total Operating Expenses | -1,281 | — | — | — | — |
| EBITDA | -196 | — | — | — | — |
| EBITDA Margin | -10.9% | — | — | — | — |
| Total D&A | -17 | — | — | — | — |
| EBIT / Operating Income | -213 | — | — | — | — |
| Total Interest Income | 3 | — | — | — | — |
| Total Interest Expense | -5 | — | — | — | — |
| Total Other Income | 69 | — | — | — | — |
| Profit Before Tax | -146 | — | — | — | — |
| Total Income Tax | 0 | — | — | — | — |
| Net Profit / (Loss) | -146 | — | — | — | — |
| Net Margin | -8.1% | — | — | — | — |
Not every picked company reports every selected year — FY2024: 4 of 5 companies have no filing. Those cells are left blank (no filing), not zero.
| Company | Sector | EBITDA margin · FY 2024 | Percentile | Sector n |
|---|---|---|---|---|
| Diamti | Medical Devices | -10.9% | 5th pct | 39 |
| Bakmed | Medical Devices | — | no FY data | 39 |
| Lateki | Medical Devices | — | no FY data | 39 |
| Tesio | Medical Devices | — | no FY data | 39 |
| MN Medikal Georgia | Medical Devices | — | no FY data | 39 |
Percentile is within each company's own sector across the whole FY2024 cross-section (1st–100th; higher = larger value). Companies with no sector, or no filing for the year, are not ranked.